Therefore, the inhibition of the miR-10b/HOXD10/MMP14 and miR-10b/KLF4/E-cadherin axes may offer potential therapeutic targets for metastatic bladder cancer [64]. This evidence concerns the gene KLF4 and urinary bladder carcinoma.